In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Troubled Valeant Pharmaceuticals has named Joseph Papa as its new chief executive, calling him an appointment with “an ethical approach.” 25 April 2016
Pharmaceutical
Maya Martinez-Davis has been appointed as global head of oncology of the biopharma business of German pharma giant Merck KGaA, it was announced on Thursday. 14 April 2016
Pharmaceutical
Starboard Value, a privately owned hedge fund sponsor, has written a strongly-worded letter to US specialty drugmaker Depomed, in which the investor now owns almost 10% of the shares. 11 April 2016
Pharmaceutical
Japanese pharma major Daiichi Sankyo this week announced its five-year business plan for the fiscal period 2016-2020. 1 April 2016
Pharmaceutical
French pharma giant Sanofi has announced the appointment of leading immunology researcher Yong-Jun Liu as its head of research. 29 March 2016
Pharmaceutical
Japanese drugmaker Sosei Group has announced that Peter Bains will take over as both chief operating officer and chief executive in the next three months. 22 March 2016
Pharmaceutical
Valeant Pharmaceuticals International today announced that it has initiated a search for a new chief executive officer, and appointed William Ackman, chief executive of hedge fund Pershing Square Management, to its board of directors. 21 March 2016
Pharmaceutical
US clinical-stage cancer drug develop Threshold Pharmaceuticals has announced the appointment of Stewart Kroll as chief operating officer. 21 March 2016
Pharmaceutical
The chief executive of UK pharma major GlaxoSmithKline, Sir Andrew Witty, will retire in March next year, the company announced on Thursday. 17 March 2016
Pharmaceutical
French drugmaker Sanofi has appointed Ameet Nathwani as its new chief medical officer, it has been announced. 10 March 2016
Pharmaceutical
Canadian drugmaker Valeant Pharmaceuticals has confirmed that executive vice president, company group chairman, Deb Jorn, has resigned from the company with immediate effect. 4 March 2016
Pharmaceutical
Japanese drug major Astellas Pharma has appointed Yukio Matsui as president of EMEA operations, with responsibility for the company’s commercial operations in Europe, the Middle East and Africa, it has been announced. 4 March 2016
Pharmaceutical
Switzerland-based privately-held drugmaker Ferring Pharmaceuticals has appointed Aaron Graff as chief executive of Ferring Holding Inc. 2 March 2016
Pharmaceutical
Swedish Orphan Biovitrum has released financial results, showing that total net revenue for the fourth quarter of 2015 has increased 15% (+9% at constant currencies) to 814 million kronor ($96.2 million). 26 February 2016
Pharmaceutical
German pharma major Bayer has announced that Werner Baumann is to take over as chairman on May 1. 25 February 2016
Pharmaceutical
UK-based life sciences firm Abzena says that its US biomanufacturing subsidiary PacificGMP has made two senior appointments to support its growth. 23 February 2016
Pharmaceutical
A new life sciences investment company, which includes former senior pharma industry executive, has commenced operations with initial funding from institutional investors. 22 February 2016
Pharmaceutical
Therapeutic Proteins International (TPI) has announced the appointment of a new chief scientific officer. 16 February 2016
Pharmaceutical
The UK's Association of the British Pharmaceutical Industry (ABPI) has named Mike Thompson as its new chief executive. 11 February 2016
Pharmaceutical
US pharma giant Pfizer has named the executive leadership team that will take up the reins after its acquisition of Irish-based Allergan is finalised at the end of this year. 9 February 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze